Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tomohiro Ochi"'
Publikováno v:
BMC Women's Health, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The evaluation of breast density is important, because dense breast has been shown to be associated with increased risk of breast cancer and a greater risk of a false-negative diagnostic performance due to masking a tumor. Althoug
Externí odkaz:
https://doaj.org/article/9ec47335098c4951ad5abf2d265692da
Autor:
Akatsuki Kondo, MD, Teruyuki Dohi, MD, PhD, Nikki Izumi, MD, Tomohiro Ochi, MD, Rei Ogawa, MD, PhD, FACS
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 9, Iss 2, p e3404 (2021)
Summary:. We previously reported cases of anterior-neck reconstruction using super-thin and perforator-supercharged skin-pedicled flaps harvested from the pectoral area and back. Here, we reconstructed a neck-scar contracture with a long skin-pedicle
Externí odkaz:
https://doaj.org/article/b669a9a9c41e4b30a102888f9f24b025
Autor:
Tomohiro Ochi, Atsushi Yoshida, Osamu Takahashi, Yuka Kajiura, Junko Takei, Naoki Hayashi, Hiroyuki Takei, Hideko Yamauchi
Publikováno v:
Breast Cancer. 30:354-363
Among younger patients, one of the important concerns is whether they can give birth safely. Although previous studies have investigated this topic, many aspects remain unclear owing to potential biases. We aimed to evaluate the prognostic effect of
Autor:
Akiko NUMATA, Tomohiro OCHI, Atsushi YOSHIDA, Naoki HAYASHI, Fumi NOZAKI, Hiroko TSUNODA, Hideko YAMAUCHI
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 83:1417-1421
Autor:
Naomi Nagura, Atsushi Yoshida, Tomohiro Ochi, Hideko Yamauchi, Naoki Hayashi, Yoshiko Iwahira, Junko Takei
Publikováno v:
Breast Cancer. 27:70-76
Breast reconstruction is a favorable option for women with BRCA1 or BRCA2 mutations (BRCA1/2Mut+) who undergo risk-reducing mastectomy (RRM). We assessed characteristics of patients who underwent RRM, with or without breast reconstruction. We include
Autor:
Tomohiro Ochi, Seigo Nakamura, Naoki Hayashi, Koyu Suzuki, Hideko Yamauchi, Maki Namura, Hiroko Tsunoda
Publikováno v:
Clinical Breast Cancer. 19:71-77
Background Magnetic resonance imaging (MRI) or ultrasonography (US) alone is limited in the ability to predict the pathologic complete response (pCR) accurately after neoadjuvant chemotherapy (NAC). The aim of the present study was to predict the pCR
Publikováno v:
Plastic and Reconstructive Surgery Global Open
Plastic and Reconstructive Surgery, Global Open, Vol 9, Iss 2, p e3404 (2021)
Plastic and Reconstructive Surgery, Global Open, Vol 9, Iss 2, p e3404 (2021)
Summary:. We previously reported cases of anterior-neck reconstruction using super-thin and perforator-supercharged skin-pedicled flaps harvested from the pectoral area and back. Here, we reconstructed a neck-scar contracture with a long skin-pedicle
Autor:
Hideko Yamauchi, Hiroyuki Takei, Koyu Suzuki, Tomohiro Ochi, Naoko Matsuda, Fumi Nozaki, Hiroko Tsunoda
Publikováno v:
Breast cancer (Tokyo, Japan). 28(4)
Neoadjuvant chemotherapy (NAC) is standard therapy in triple-negative breast cancer (TNBC) and HER2-positive breast cancer (HER2 + ve BC). There are concerns about the accurate imaging modalities to measure residual tumor during or after NAC. Up to n
Autor:
Michiko Ando, Hideko Yamauchi, Hiroyuki Takei, Takayuki Iwamoto, Junko Takei, Giuseppe Curigliano, Koyu Suzuki, Fumi Nozaki, Daiki Kobayashi, Tomohiro Ochi, Atsushi Yoshida, Giampaolo Bianchini, Naoki Hayashi, Naoki Niikura, Carmen Criscitiello
Publikováno v:
European journal of cancer (Oxford, England : 1990). 118
Aim Lymphocyte predominant breast cancer (BC) is associated with higher pathological complete response (pCR) rate after neoadjuvant therapy (NAT) and favorable outcome in triple negative breast cancer (TNBC) and HER2+ BC. The predictive and prognosti
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(10)
Following the discovery that the prognostic impact of preoperative chemotherapy depends on the primary breast cancer subtype, the treatment strategy for primary breast cancer changed. Pathologic complete response(pCR)with preoperative chemotherapy is